-
Mashup Score: 1AMP Amyotrophic Lateral Sclerosis | FNIH - 7 hour(s) ago
The Accelerating Medicines Partnership® (AMP®) Amyotrophic Lateral Sclerosis (AMP ALS) is accelerating therapeutic and biomarker development for familial and sporadic ALS by addressing the challenges of disease heterogeneity, fragmented research efforts, and a lack of standardized tools.
Source: fnih.orgCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 37
• The Accelerating Medicines Partnership® in Amyotrophic Lateral Sclerosis (AMP® ALS) will create the largest open data platform for ALS research • Partnership will enable discovery and development of diagnostic tools, biomarkers, and better treatments NORTH BETHESDA, Md., May 21, 2024—The Foundation for the National Institutes of Health (FNIH) announces the launch of a […]
Source: fnih.orgCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 1Biomarkers Consortium – CSC Scientific Symposium | The Foundation for the National Institutes of Health - 2 year(s) ago
Aligning diverse stakeholders within cancer research to accelerate progress
Source: fnih.orgCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 5
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium (BC) has launched a project that signals a paradigm shift in our methods to image the brain.
Source: fnih.orgCategories: Addiction Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
The Foundation for the National Institutes of Health (FNIH) and the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) are launching a new partnership to investigate the syndrome of heart failure with preserved ejection fraction (HFpEF).
Source: fnih.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 6Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (AMP® BGTC) | The Foundation for the National Institutes of Health - 2 year(s) ago
Streamlining Adeno-Associated Virus (AAV) manufacturing and regulatory frameworks to increase accessibility of gene therapies for rare diseases
Source: fnih.orgCategories: Latest Headlines, Rare DiseaseTweet-
The Bespoke Gene Therapy Consortium has reissued new AAV research opportunities! Learn more: https://t.co/ZaaFFtWx9O #RareDisease #GeneTherapy @FNIH_Org
-
-
Mashup Score: 3
February 28, 2022 – The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a new project that will identify the best blood tests to measure a protein that is instrumental in the early detection of rare neurodegenerative diseases. The “Neurofilament as a Fluid Biomarker of Neurodegeneration in Familial Frontotemporal Degeneration…
Source: fnih.orgCategories: Addiction Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (AMP® BGTC) | The Foundation for the National Institutes of Health - 2 year(s) ago
Streamlining Adeno-Associated Virus (AAV) manufacturing and regulatory frameworks to increase accessibility of gene therapies for rare diseases
Source: fnih.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
NIBR is proud to be a founding member of the AMP #BespokeGeneTherapyConsortium to streamline the development of and access to #genetherapy as treatment for rare genetic diseases. More about the consortium here @FNIH_Org: https://t.co/mQyXer49Vy #RareDiseaseDay #ShowYourStripes https://t.co/3tD3NusNut
-
-
Mashup Score: 10Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (AMP® BGTC) | The Foundation for the National Institutes of Health - 2 year(s) ago
Streamlining Adeno-Associated Virus (AAV) manufacturing and regulatory frameworks to increase accessibility of gene therapies for rare diseases
Source: fnih.orgCategories: Latest Headlines, Rare DiseaseTweet-
The deadline for the open Requests for Proposals (RFPs) and Disease Nomination Form for the BGTC is approaching! Researchers, clinicians, and patient advocates interested in these AAV biology and clinical opportunities must submit by February 18. Visit: https://t.co/ZaaFFtWx9O https://t.co/WBawYfQjFi
-
-
Mashup Score: 2Accelerating Medicines Partnership® (AMP®) Bespoke Gene Therapy Consortium Webinar | The Foundation for the National Institutes of Health - 2 year(s) ago
The Accelerating Medicines Partnership® (AMP®) Bespoke Gene Therapy Consortium (BGTC) will host an informational webinar for prospective submitters discussing the open Requests for Proposals (RFPs) and disease nomination form submission processes on January 6, 2022 from 1-2pm ET. To access the webinar on January 6th, please click here. The webinar will open at…
Source: fnih.orgCategories: Latest Headlines, Rare DiseaseTweet
RT @BrielmaierL: AMP-ALS Website https://t.co/dtxTk3hlEr